D
Achieve Life Sciences, Inc. ACHV
$4.74 $0.0450.96%
Recommendation
Sell
Prev Close
$4.51
Volume
76,066
Avg Vol (90D)
111,145
Market Cap
$154.48M
Dividend & Yield
--
52-Week Range
$3.03 - $10.30
P/E (TTM)
--
EPS (TTM)
-$1.53
My Lists My Alerts
Report
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Fair
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Achieve Life Sciences (ACHV, $4.52) price moved above its 50-day Moving Average on May 01, 2024
5/2/2024 - Tickeron - Stocks
Achieve Life Sciences (ACHV, $4.52) entered Downtrend as Momentum indicator drops below 0 level on May 01, 2024
5/2/2024 - Tickeron - Stocks
Achieve Life Sciences (ACHV, $4.39) price exceeded its 50-day Moving Average on April 30, 2024
5/1/2024 - Tickeron - Technical Analysis
Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV
4/29/2024 - Accesswire
Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024
4/25/2024 - Globe Newswire
Raymond James & Associates Raises Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV)
4/25/2024 - Zolmax
Achieve Life Sciences (ACHV, $4.5) price moved above its 50-day Moving Average on April 23, 2024
4/24/2024 - Tickeron - Stocks
Achieve Life Sciences (ACHV, $4.5) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 23, 2024
4/24/2024 - Tickeron - Stocks
Achieve Life Sciences (ACHV, $4.41) Moving Average Convergence Divergence (MACD) Histogram turned negative on April 22, 2024
4/23/2024 - Tickeron - Stocks
Achieve Life Sciences (ACHV, $4.41) price exceeded its 50-day Moving Average on April 22, 2024
4/23/2024 - Tickeron - Stocks
Achieve Life Sciences (NASDAQ:ACHV) Research Coverage Started at Jonestrading
4/21/2024 - Ticker Report
Achieve Life Sciences (NASDAQ:ACHV) Coverage Initiated by Analysts at Jonestrading
4/20/2024 - Zolmax
Achieve Life Sciences (ACHV, $4.57) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 18, 2024
4/19/2024 - Tickeron - Stocks
Achieve Life Sciences (ACHV, $4.57) price moved above its 50-day Moving Average on April 17, 2024
4/18/2024 - Tickeron - Stocks
Achieve Life Sciences (NASDAQ:ACHV) Receives New Coverage from Analysts at Jonestrading
4/18/2024 - Zolmax
Jones starts Achieve Life Sciences at buy, cites market opportunity
4/17/2024 - Seeking Alpha - Healthcare
Jones starts Achieve Life Sciences at buy, cites market opportunity
4/17/2024 - SeekingAlpha.com: All News
Achieve Life Sciences (ACHV, $4.38) price exceeded its 50-day Moving Average on April 16, 2024
4/17/2024 - Tickeron - Stocks
Achieve Life Sciences: A Strong Buy for Tobacco Cessation Market Penetration
4/16/2024 - TipRanks Financial Blog
Achieve Life Sciences initiated with bullish view at JonesResearch, here's why
4/16/2024 - The Fly
Achieve Life Sciences (ACHV, $4.45) price moved above its 50-day Moving Average on April 15, 2024
4/16/2024 - Tickeron - Stocks
Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference
4/11/2024 - Globe Newswire
Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200-Day Moving Average of $4.40
4/9/2024 - Zolmax
Achieve Life Sciences: An Excellent Drug Addressing A Large Market Could Drive 5x Returns
4/4/2024 - SeekingAlpha
Achieve Life Sciences: An Excellent Drug Addressing A Large Market Could Drive 5x Returns
4/4/2024 - Seeking Alpha - Long Ideas
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$27.02M
EBIT (TTM)
-$27.25M
Net Income (TTM)
-$29.82M
Balance Sheet
Total Assets (Q)
$19.37M
Total Debt (Q)
$16.73M
Total Liabilities (Q)
$20.82M
Book Value Per Share (Q)
-$0.0684
Cash Flow
Cash from Operations (TTM)
-$24.48M
Cash from Investing (TTM)
-$21.00K
Cash from Financing (TTM)
$15.28M
Net Change in Cash (TTM)
-$9.23M
Filings
Filing Date
Thursday, March 28, 2024
Period Date
Sunday, December 31, 2023
Next Filing
Week of May 6 and 10 (est)
Price History
Loading...
Beta
0.79
7-Day Total Return
0.00%
30-Day Total Return
2.47%
60-Day Total Return
-7.30%
90-Day Total Return
43.71%
Year to Date Total Return
9.59%
1-Year Total Return
-43.86%
2-Year Total Return
-33.77%
3-Year Total Return
-60.26%
5-Year Total Return
-94.75%
52-week Low
Dec 12, 2023 - $3.03
52-week High
May 11, 2023 - $10.30
Valuation
Market Cap
$154.48M - Micro Cap
Enterprise Value
$155.66M
Price/Sales (TTM)
--
Price/Book (Q)
-65.94
Dividends and Shares
Shares Outstanding
21.17M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.achievelifesciences.com
Phone Number
604 210 2217
Address
1040 West Georgia Street
Vancouver, BC V6E 4H1
Country
Canada
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the... more
NASDAQ 05/03/2024 4:00PM Eastern Quotes delayed
Weiss Ratings